Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Volkmar Mueller
Introduction
Volkmar Mueller is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of medical technology, particularly in the area of cancer prognosis. His work focuses on innovative methods that enhance the understanding and treatment of breast cancer.
Latest Patents
One of Volkmar Mueller's notable patents is titled "Methods for the prognosis of breast cancer." This invention relates to modified and genomic sequences, as well as oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genomic DNA. The patent also outlines a method for predicting disease-free survival and/or response of a subject with a cell proliferative disorder of the breast tissues to endocrine treatment. This patent showcases his commitment to advancing cancer research and improving patient outcomes.
Career Highlights
Volkmar Mueller is associated with Epigenomics AG, a company that specializes in the development of innovative cancer diagnostics. His role at the company allows him to apply his expertise in genomics and molecular biology to create impactful solutions for breast cancer prognosis.
Collaborations
Throughout his career, Volkmar has collaborated with esteemed colleagues such as John Foekens and Nadia Harbeck. These partnerships have further enriched his research and contributed to the advancement of cancer diagnostics.
Conclusion
Volkmar Mueller's innovative work in breast cancer prognosis exemplifies the vital role of inventors in the medical field. His contributions not only enhance scientific understanding but also pave the way for improved treatment options for patients.